Key patient eligibility criteria for HCC Studies include:

• Patients between 18 and 80 years of age (inclusive)
• Diagnosis or suspected HCC
• Inadequate response, loss of response, or intolerance to prior treatment
• Life expectancy >3 months
• No other primary cancers
• Willing to travel to the site for study visits.